Keyphrases
Mitogen-activated Protein Kinase
100%
Sorafenib
100%
Adenocarcinoma Cells
100%
Barrett's Adenocarcinoma
100%
Bile Acids
85%
Cyclin D1 (CCND1)
42%
Barrett
42%
Cell Proliferation
28%
Dysplasia
28%
Adenocarcinoma
28%
Taurocholate
28%
Barrett's Esophageal Cancer
28%
Cell-derived
14%
Cell Growth
14%
Neoplasia
14%
Western Blotting
14%
Kinase Activation
14%
Acid Reflux
14%
Acid Exposure
14%
Esophageal Adenocarcinoma
14%
BRAF Inhibitor (BRAFi)
14%
Cell Cycle Regulators
14%
Esophageal Cancer Cells
14%
Cancer Cell Proliferation
14%
Barrett's Metaplasia
14%
Orally Active
14%
Colorimetric Assay
14%
SCell
14%
Acid pH
14%
WST-1
14%
Phospho-p38
14%
Phospho-ERK
14%
Pharmacology, Toxicology and Pharmaceutical Science
Sorafenib
100%
Mitogen Activated Protein Kinase
100%
Esophageal Adenocarcinoma
100%
Bile Acid
85%
Cyclin D1
42%
Esophagus Cancer
28%
Dysplasia
28%
Adenocarcinoma
28%
Taurocholic Acid
28%
Western Blot
14%
Metaplasia
14%
Neoplasm
14%